Trump administration backs off endorsement of drug as ‘exciting’ autism treatment
The Trump administration withdrew its endorsement of leucovorin as an autism treatment, stating there is insufficient evidence to support its efficacy.
US authorities change position on possible treatment for autism
US regulatory agency FDA reverses approval for a controversial autism treatment initially announced by the Trump administration.